Bibliographic Details
| Title: |
764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with advanced solid tumors |
| Authors: |
Benjamin Thompson, Li Yao, Yana G Najjar, Siwen Hu-Lieskovan, Raphael Clynes, Bartosz Chmielowski, Mark N Stein, Sarina A Piha-Paul, Patricia McGovern, Judy S Wang, Benjamin Garmezy, Manojkumar Bupathi, Jitendra Kanodia |
| Source: |
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Publisher Information: |
BMJ Publishing Group, 2023. |
| Publication Year: |
2023 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2051-1426 |
| Relation: |
https://doaj.org/toc/2051-1426 |
| DOI: |
10.1136/jitc-2023-SITC2023.0764 |
| Access URL: |
https://doaj.org/article/4e505ba3340346a2a833640f1301e0f0 |
| Accession Number: |
edsdoj.4e505ba3340346a2a833640f1301e0f0 |
| Database: |
Directory of Open Access Journals |
